Challenges for CNV interpretation in clinical molecular karyotyping: Lessons learned from a 1001 sample experience

被引：86

作者：

Buysse, Karen ^{[1
]}

Delle Chiaie, Barbara ^{[1
]}

Van Coster, Rudy ^{[2
]}

Loeys, Bart ^{[1
]}

De Paepe, Anne ^{[1
]}

Mortier, Geert ^{[1
]}

Speleman, Frank ^{[1
]}

Menten, Bjoern ^{[1
]}

机构：

[1] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium

[2] Ghent Univ Hosp, Dept Pediat, B-9000 Ghent, Belgium

来源：

EUROPEAN JOURNAL OF MEDICAL GENETICS | 2009年 / 52卷 / 06期

基金：

比利时弗兰德研究基金会;

关键词：

Molecular karyotyping; Array CGH; Copy number variation; Mental retardation; Guidelines; COMPARATIVE GENOMIC HYBRIDIZATION; CONSTITUTIONAL GENETIC DIAGNOSIS; COPY NUMBER VARIATION; MENTAL-RETARDATION; ARRAY-CGH; MICRODELETION SYNDROME; CONGENITAL-ANOMALIES; STRUCTURAL VARIATION; DELETION; MICROARRAYS;

D O I：

10.1016/j.ejmg.2009.09.002

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Molecular karyotyping has moved from bench to bedside for the genetic screening of patients with mental retardation and/or congenital anomalies. The commercial availability of high-resolution microarray platforms has significantly facilitated this process. However, the notion that copy number variants are also abundantly present in the general population challenges the interpretation of the clinical significance of detected copy number variants (CNVs) in these patients. Moreover, the awareness of incomplete penetrance and variable expression, exemplified by the inheritance of causal CNVs from apparently unaffected parents, has further blurred the boundary between benign and pathogenic variation. We analyzed 1001 patients using a large insert clone array (298 patients) and an oligonucleotide-based (703 patients) platform. In this cohort we encountered several examples of causal imbalances that could have been easily interpreted as benign variants when relying on established paradigms. Based on our experience and the pitfalls we encountered, we suggest a decision tree that can be used as a guideline in clinical diagnostics. Using this workflow, we detected 106 clinically significant CNVs in 100 patients, giving a diagnostic yield of at least 10%. Of these imbalances, 58 occurred de nova, 22 were inherited and 26 of unknown inheritance. This underscores that inherited CNVs should not be automatically disregarded as benign variants. Among the clinically relevant CNVs were 11 single-gene aberrations, highlighting the power of high-resolution molecular karyotyping to identify causal genes. (C) 2009 Elsevier Masson SAS. All rights reserved.

引用

页码：398 / 403

页数：6

共 38 条

[1] A novel genomic disorder:: a deletion of the SACS gene leading to Spastic Ataxia of Charlevoix-Saguenay [J].

Breckpot, Jeroen ;

Takiyama, Yoshihisa ;

Thienpont, Bernard ;

Van Vooren, Steven ;

Vermeesch, Joris Robert ;

Ortibus, Els ;

Devriendt, Koenraad .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (09) :1050-1054

[2] Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities [J].

Brunetti-Pierri, Nicola ;

Berg, Jonathan S. ;

Scaglia, Fernando ;

Belmont, John ;

Bacino, Carlos A. ;

Sahoo, Trilochan ;

Lalani, Seema R. ;

Graham, Brett ;

Lee, Brendan ;

Shinawi, Marwan ;

Shen, Joseph ;

Kang, Sung-Hae L. ;

Pursley, Amber ;

Lotze, Timothy ;

Kennedy, Gail ;

Lansky-Shafer, Susan ;

Weaver, Christine ;

Roeder, Elizabeth R. ;

Grebe, Theresa A. ;

Arnold, Georgianne L. ;

Hutchison, Terry ;

Reimschisel, Tyler ;

Amato, Stephen ;

Geragthy, Michael T. ;

Innis, Jeffrey W. ;

Obersztyn, Ewa ;

Nowakowska, Beata ;

Rosengren, Sally S. ;

Bader, Patricia I. ;

Grange, Dorothy K. ;

Naqvi, Sayed ;

Garnica, Adolfo D. ;

Bernes, Saunder M. ;

Fong, Chin-To ;

Summers, Anne ;

Walters, W. David ;

Lupski, James R. ;

Stankiewicz, Pawel ;

Cheung, Sau Wai ;

Patel, Ankita .

NATURE GENETICS, 2008, 40 (12) :1466-1471

[3] Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice [J].

Bruno, D. L. ;

Ganesamoorthy, D. ;

Schoumans, J. ;

Bankier, A. ;

Coman, D. ;

Delatycki, M. ;

Gardner, R. J. M. ;

Hunter, M. ;

James, P. A. ;

Kannu, P. ;

McGillivray, G. ;

Pachter, N. ;

Peters, H. ;

Rieubland, C. ;

Savarirayan, R. ;

Scheffer, I. E. ;

Sheffield, L. ;

Tan, T. ;

White, S. M. ;

Yeung, A. ;

Bowman, Z. ;

Ngo, C. ;

Choy, K. W. ;

Cacheux, V. ;

Wong, L. ;

Amor, D. J. ;

Slater, H. R. .

JOURNAL OF MEDICAL GENETICS, 2009, 46 (02) :123-131

[4]

Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]

[5] The 12q14 microdeletion syndrome: Additional patients and further evidence that HMGA2 is an important genetic determinant for human height [J].

Buysse, Karen ;

Reardon, William ;

Mehta, Lakshmi ;

Costa, Teresa ;

Fagerstrom, Carrie ;

Kingsbury, Daniel J. ;

Anadiotis, George ;

McGillivray, Barbara C. ;

Hellemans, Jan ;

de Leeuw, Nicole ;

de Vries, Bert B. A. ;

Speleman, Frank ;

Menten, Bjorn ;

Mortier, Geert .

EUROPEAN JOURNAL OF MEDICAL GENETICS, 2009, 52 (2-3) :101-107

[6] Mapping and sequencing chromosome breakpoints [J].

Carter, NP .

CYTOMETRY, 2002, :43-43

[7] Molecular karyotyping of patients with MCA/MR: the blurred boundary between normal and pathogenic variation [J].

de Ravel, T. J. L. ;

Balikova, I. ;

Thienpont, B. ;

Hannes, F. ;

Maas, N. ;

Fryns, J. -P. ;

Devriendt, K. ;

Vermeesch, J. R. .

CYTOGENETIC AND GENOME RESEARCH, 2006, 115 (3-4) :225-230

[8]

GIJSBERS AC, 2009, EUR J HUM GENET 0513

[9]

Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4

[10] Detection of large-scale variation in the human genome [J].

Iafrate, AJ ;

Feuk, L ;

Rivera, MN ;

Listewnik, ML ;

Donahoe, PK ;

Qi, Y ;

Scherer, SW ;

Lee, C .

NATURE GENETICS, 2004, 36 (09) :949-951

← 1 2 3 4 →